Stock A170900 DONG-A ST CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company Dong-A ST Co., Ltd.

Equities

A170900

KR7170900005

Pharmaceuticals

End-of-day quote Korea S.E.
Other stock markets
 06:00:00 2024-04-16 pm EDT 		5-day change 1st Jan Change
66,400 KRW -1.92% Intraday chart for Dong-A ST Co., Ltd. -2.21% -3.91%
Mar. 18 Dong-A ST Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Jan. 24 GenEdit Inc. announced that it has received $24 million in funding from Korea Innovative Medicines Consortium, Dong-A ST Co., Ltd., Huons Co., Ltd. CI

Business Summary

Dong-A ST Co Ltd is a Korea-based company mainly engaged in the production and sale of pharmaceuticals. The Company is involved of the manufacturing and sale of gastric mucosal protective agents, antihistamines, ischemic modifiers, antithrombotic agents, functional dyspepsia, hyperlipidemia, growth hormone, peptic ulcer treatments, cerebral metabolism improvement and hypertension treatments. It produces and sells diagnostic reagents for hepatitis E, I, A and B. In addition, it is engaged in the production and sale of medical devices including implants for artificial joint and maxillofacial surgery. The Company distributes its products in domestic and overseas markets such as Brazil, Turkey and Cambodia.

Number of employees: 1,662

Sales per Business

KRW in Million2022Weight2023Weight Delta
Pharmaceutical Products
100.0 %
635,393 100.0 % 663,980 100.0 % +4.50%

Sales per region

KRW in Million2022Weight2023Weight Delta
South Korea
77.4 %
469,817 73.9 % 514,011 77.4 % +9.41%
Southeast Asia
11.9 %
103,945 16.4 % 79,060 11.9 % -23.94%
East Asia
4.7 %
28,383 4.5 % 31,319 4.7 % +10.35%
Europe
3.2 %
10,563 1.7 % 21,133 3.2 % +100.06%
Others
1.4 %
8,131 1.3 % 9,442 1.4 % +16.13%
South America
0.7 %
9,986 1.6 % 4,886 0.7 % -51.07%
United States
0.6 %
4,569 0.7 % 4,129 0.6 % -9.62%

Managers

Managers TitleAgeSince
Min-Young Kim CEO
 Chief Executive Officer 52 -
Jae-Hong Park PSD
 President 55 -
Seong-Geun Lee BRD
 Director/Board Member 53 -

Members of the board

Members of the board TitleAgeSince
Beom-Jun Kim BRD
 Director/Board Member 50 -
Min-Young Kim CEO
 Chief Executive Officer 52 -
Jae-Sang Ryu BRD
 Director/Board Member 54 -
Hui-Joo Choi BRD
 Director/Board Member 58 -
Seong-Geun Lee BRD
 Director/Board Member 53 -
Hak-Jun Kim BRD
 Director/Board Member 56 20-03-23
Jae-Hong Park PSD
 President 55 -

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 8,665,922 4,426,612 ( 51.08 %) 188,647 ( 2.177 %) 51.08 %

Shareholders

NameEquities%Valuation
DONG-A SOCIO HOLDINGS CO., LTD.
27.59 %
2,377,047 27.59 % 131 M ₩
GSK PLC
8.381 %
722,016 8.381 % 40 M ₩
National Pension Service of Korea
7.807 %
672,539 7.807 % 37 M ₩
Dong A St Co. Ltd. Esoa
6.865 %
591,456 6.865 % 33 M ₩
OTSUKA HOLDINGS CO., LTD.
6.296 %
542,382 6.296 % 30 M ₩
DONG-A ST CO., LTD.
2.147 %
184,948 2.147 % 10 M ₩
Sooseok Foundation
0.5368 %
46,244 0.5368 % 3 M ₩
SangJu School
0.3593 %
30,955 0.3593 % 2 M ₩
Jung-Seok Kang
0.3407 %
29,349 0.3407 % 2 M ₩
SINTOKOGIO,LTD.
0.1631 %
14,051 0.1631 % 773 392 ₩

Holdings

NameEquities%Valuation
NEUROBO PHARMACEUTICALS, INC.
57.79%
 2,803,699 57.79% 11,467,129 $
DONG-A ST CO., LTD.
2.15%
 184,948 2.15% 10,179,867 $

Company contact information

Dong-A ST Co., Ltd.

64 Cheonhodae-ro Dongdaemun-gu

02587, Seoul

+

http://www.donga-st.com
address Dong-A ST Co., Ltd.(A170900)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Specialty & Advanced Pharmaceuticals

Sales per region

Ratings for Dong-A ST Co., Ltd.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

EPS Revisions

Estimates Revisions

Quarterly revenue - Rate of surprise

Company calendar

Sector Specialty & Advanced Pharmaceuticals

1st Jan change Capi.
DONG-A ST CO., LTD. Stock Dong-A ST Co., Ltd.
-3.91% 410M
MERCK KGAA Stock Merck KGaA
+0.14% 68.09B
KYOWA KIRIN CO. LTD. Stock Kyowa Kirin Co. Ltd.
+11.18% 9.08B
SK BIOPHARMACEUTICALS CO., LTD. Stock SK Biopharmaceuticals Co., Ltd.
-19.62% 4.57B
SHENYANG XINGQI PHARMACEUTICAL CO.,LTD. Stock Shenyang Xingqi Pharmaceutical Co.,Ltd.
+24.23% 3.9B
YUHAN CORPORATION Stock Yuhan Corporation
-0.44% 3.69B
INDIVIOR PLC Stock Indivior PLC
+30.04% 2.62B
CHANGCHUN BCHT BIOTECHNOLOGY CO. Stock Changchun BCHT Biotechnology Co.
-25.01% 2.34B
BETTA PHARMACEUTICALS CO., LTD. Stock Betta Pharmaceuticals Co., Ltd.
-28.30% 2.14B
SHANGHAI SHYNDEC PHARMACEUTICAL CO., LTD. Stock Shanghai Shyndec Pharmaceutical Co., Ltd.
+1.33% 1.84B
Specialty & Advanced Pharmaceuticals
  1. Stock Market
  2. Equities
  3. A170900 Stock
  4. Company Dong-A ST Co., Ltd.